Search results for "Highlights"
Beta-blocker monotherapy may be preferred for primary prophylaxis of esophageal variceal bleeding
Guidelines currently recommend nonselective beta-blockers or variceal band ligation for primary prevention of variceal bleeding based on similar efficacy, but survival benefit may be better with the former treatment.
https://gastroenterology.acponline.org/archives/2018/08/24/2.htm
24 Aug 2018
H. pylori treatment, supplements linked to improved gastric cancer outcomes
A randomized trial of high-risk patients in China found that Helicobacter pylori treatment, vitamin supplementation, and garlic supplementation were associated with significant reductions in gastric cancer mortality.
https://gastroenterology.acponline.org/archives/2019/09/27/1.htm
27 Sep 2019
Low-volume bowel prep appears as effective as high-volume for colonoscopy
No significant between-group differences were seen for low-volume versus high-volume split-dose regimens in adequacy of bowel cleansing, while low-volume regimens had higher odds of patient adherence or completion, tolerability, and willingness to repeat.
https://gastroenterology.acponline.org/archives/2019/11/22/1.htm
22 Nov 2019
Screening for Lynch syndrome less effective at older ages, study finds
Lynch syndrome is rare after age 80 years, making the efficiency of universal screening very low, so stopping reflex screening in this age group may be reasonable, particularly in resource-limited settings, the study authors said.
https://gastroenterology.acponline.org/archives/2019/06/28/1.htm
28 Jun 2019
USPSTF continues to recommend against screening for pancreatic cancer
There is no evidence that screening for pancreatic cancer or treating screen-detected disease improves disease-specific morbidity or all-cause mortality in average-risk adults with no symptoms, the U.S. Preventive Services Task Force (USPSTF) concluded.
https://gastroenterology.acponline.org/archives/2019/08/23/1.htm
23 Aug 2019
Rates of HDV co-infection may be higher than previously estimated
Patients with chronic hepatitis B virus (HBV) and hepatitis D virus (HDV) co-infection have the most severe form of viral hepatitis and are at much higher risk for cirrhosis and hepatocellular cancer than patients with HBV infection alone.
https://gastroenterology.acponline.org/archives/2018/09/28/3.htm
28 Sep 2018
Guideline recommends standardized management of mild to moderate ulcerative colitis
The guideline focuses on oral and topical 5-aminosalicylic acid medications, rectal corticosteroids, and oral budesonide in patients with mild to moderate disease.
https://gastroenterology.acponline.org/archives/2018/12/28/2.htm
28 Dec 2018
Boxed warning added to liver disease drug
The drug has been incorrectly dosed daily instead of weekly in patients with moderate to severe primary biliary cholangitis, which increases the risk of serious liver injury, the FDA said.
https://gastroenterology.acponline.org/archives/2018/02/23/7.htm
23 Feb 2018
Halting one ulcerative colitis treatment after escalating to new drug may be feasible, study finds
Patients with ulcerative colitis treated with 5-aminosalicylates who require escalation to anti-tumor necrosis factor-alpha (anti-TNF) therapy may be able to safely discontinue the first drug.
https://gastroenterology.acponline.org/archives/2018/11/27/3.htm
27 Nov 2018
Induction, maintenance therapies for ulcerative colitis compared
Oral sulfasalazine, diazo-bonded 5-aminosalicylates (5-ASAs), mesalazine, controlled ileal-release budesonide, and budesonide multimatrix, alone or in combination with rectal 5-ASA therapy, were assessed for comparative efficacy and tolerability.
https://gastroenterology.acponline.org/archives/2018/08/24/3.htm
24 Aug 2018